Combined Pill vs Mini-Pill vs Slynd: How Providers Actually Choose

The short version

Every birth control pill on the US market is one of three things. A combined pill pairs estrogen with a progestin and is the default for most people. The traditional mini-pill (norethindrone) drops the estrogen but demands the same 3-hour window every single day. [1] Slynd (drospirenone) also skips estrogen but forgives a pill taken up to 24 hours late. [2]

Which one you get should follow from two questions: does your history allow estrogen, and how realistic is your relationship with a daily alarm? This article is the choosing logic written out, including the honest downsides of each.

The combined pill: the default, and why

Combined pills carry ethinyl estradiol (modern pills are 35 micrograms or less) plus a progestin, in packs of 21 active pills and 7 inactive, or 24 plus 4. [3] The estrogen buys cycle control: bleeding tends to be regular, lighter, and less crampy, and combined pills carry documented long-term reductions in ovarian and endometrial cancer risk. [8] Taken at roughly the same time daily they are forgiving; the practical failure rate with typical use is about 7 in 100 per year, almost all of it from missed pills, versus well under 1 in 100 with perfect use. [6]

Who does not get it. The estrogen is the liability: migraine with aura, smoking heavily at 35 or older, clot history, and uncontrolled high blood pressure all move you off combined pills entirely. [4] The full screening is in what your provider checks first.

The norethindrone mini-pill: strict but proven

Norethindrone 0.35 mg is taken every day with no break between packs, and it works mainly by thickening cervical mucus rather than reliably stopping ovulation. That mechanism is why the timing rule is brutal: more than 3 hours late counts as a miss and means backup contraception for the next 48 hours. [1]

It is a fine pill for people with rock-solid routines and the standard answer during breastfeeding and for anyone barred from estrogen. It is a frustrating pill for anyone whose schedule shifts, and irregular spotting is its signature complaint. [1] If the 3-hour window keeps tripping you, that exact problem has a dedicated article: switching from the strict window to Slynd.

Slynd: progestin-only with modern manners

Slynd is drospirenone 4 mg in a 24 active plus 4 inactive pack, taken at the same time daily by intention, but it suppresses ovulation strongly enough that a pill up to 24 hours late does not count as missed; 48 hours late does. [2] That single property makes it the usual recommendation for someone who needs estrogen-free and knows themselves well enough to distrust a 3-hour window.

Its one specific caution: drospirenone is related to spironolactone and can raise potassium. Kidney or adrenal disease rules it out, and anyone on daily potassium-raising medication (some blood pressure drugs, long-term NSAIDs) should have a potassium level checked around starting. [2] That is the one situation in pill prescribing where a lab actually enters the picture.

The choosing logic, written out

• History allows estrogen, and you want the most forgiving cycle. Combined pill. [4]
• Estrogen is barred, schedule is ironclad, or you are breastfeeding. Norethindrone mini-pill. [1][4]
• Estrogen is barred and your days are unpredictable. Slynd, potassium caution permitting. [2]
• You want no prescription at all. Opill, a norgestrel mini-pill, is available over the counter; the same 3-hour discipline logic applies. Honest answer: if it fits, you do not need a visit.
• Pills keep failing you regardless of type. The better conversation is long-acting methods (IUD, implant), which a telehealth service cannot place but can refer you toward honestly.

What switching looks like

Moving between pills is routine and does not require finishing a pack in either direction; the standard patterns are starting the new pill the day the old pack would have continued, with backup rules depending on the switch. [2][7] The point is that a first choice is not a life sentence: the 3-month review exists partly to catch a bad fit, covered in the follow-up article. Whichever pill you land on, learn the start and missed-pill rules and the warning signs once.

What it costs with Well Revolution

$80 for the Limited Treatment Plan. If approved, you will receive a 90 day treatment plan with 7 days a week support. Perfect for first time patients who are trying it out.

Or $90 for the Unlimited Membership. If approved, you will receive 3 months of care with 7 days a week support, plus unlimited prescriptions, lab tests, imaging orders, letters and referrals with same day care, cancel anytime, no fees. Perfect for established patients looking for full care.

Getting started with Well Revolution

A licensed US provider walks this exact logic against your history in chat, same day, and writes the pill that fits rather than the one a template defaults to. If the fit turns out wrong at follow-up, switching is a message, not a new visit fee. Message us and we confirm coverage in your state. The full process starts at how to get birth control pills online.

References

1. Heather (norethindrone) prescribing information, via FDA DailyMed. DailyMed
2. Slynd (drospirenone) prescribing information, via FDA DailyMed. DailyMed
3. Sprintec (norgestimate and ethinyl estradiol) prescribing information, via FDA DailyMed. DailyMed
4. Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recommendations and Reports, 2024. PubMed 39106314
5. Curtis KM, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. MMWR Recommendations and Reports, 2024. PubMed 39106301
6. Sundaram A, et al. Contraceptive Failure in the United States: Estimates from the 2006-2010 National Survey of Family Growth. 2017. PubMed 28245088
7. Switching guidance summarized from the Slynd and Sprintec labels' starting/switching instructions: see references 2 and 3.
8. Teal S, Edelman A. Contraception Selection, Effectiveness, and Adverse Effects: A Review. JAMA, 2021. PubMed 34962522

Reviewed by PA Michael Rubio, US Medical Director